Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A phase I/II study of combined therapy with Th17-inducing dendritic cells and pembrolizumab in patients with recurrent epithelial ovarian cancer
Knutson, K. L. (PI) & Block, M. S. (CoPI)
7/1/23 → 6/30/25
Project: Research project
-
Phase 1 Clinical Trial of a Novel HER2 Vaccine for Patients with DCIS
Knutson, K. L. (PI)
9/30/16 → …
Project: Research project
-
Next Generation TOP1 Inhibition for the Treatment of Uterine Serous Carcinoma
Kaufmann, S. H. (PI), Bell, D. (CoPI), Bible, K. C. (CoPI), Cliby, W. A. (CoPI), Couch, F. F. J. (CoPI), Fields, A. P. (CoPI), Galanis, E. (CoPI), Goode, E. L. (CoPI), Haluska, P. R. J. (CoPI), Hartmann, L. C. (CoPI), Karnitz, L. M. (CoPI), Keeney, G. (CoPI), Knutson, K. L. (CoPI), Lengyel, E. (CoPI), Lingle, W. L. (CoPI), Long, H. (CoPI), Sherman, M. M. E. (CoPI), Moriarity, B. S. (CoPI), Block, M. S. (CoPI), Oberg, A. L. (CoPI), Peng, K.-W. (CoPI), Shridhar, V. (CoPI) & Weroha, S. (CoPI)
9/1/09 → 8/31/25
Project: Research project
-
Cancer Immunology and Immunotherapy Program
Knutson, K. L. (PI), Knutson, K. K. L. (PI) & Pease, L. R. (PI)
3/1/19 → 2/29/24
Project: Research project
-
Combination Trastuzumab and Vaccine Therapy to Prevent Disease Recurrence in Locally Advanced HER2+ Breast Cancer
Knutson, K. L. (PI)
Congressionally Directed Medical Research Programs
9/30/18 → 9/29/22
Project: Research project
-
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression
Sigarteu Chindris, A. M., Rivera, M., Ma, Y., Nair, A., Liu, Y., Wang, X., Necela, B. M., Kachergus, J. M., Casler, J. D., Brett, C., Rivas Mejia, A. M., Bernet, V. J., Copland, J. A., Knutson, K. L., Thompson, E. A. & Smallridge, R. C., 2024, In: Frontiers in Endocrinology. 15, 1440722.Research output: Contribution to journal › Article › peer-review
Open Access -
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
Wickland, D. P., McNinch, C., Jessen, E., Necela, B., Shreeder, B., Lin, Y., Knutson, K. L. & Asmann, Y. W., May 15 2024, In: Journal for ImmunoTherapy of Cancer. 12, 5, e008988.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
Gabriel, E. M., Necela, B., Bahr, D., Vivekanandhan, S., Shreeder, B., Bagaria, S. & Knutson, K. L., Dec 2024, In: Scientific reports. 14, 1, 24545.Research output: Contribution to journal › Article › peer-review
Open Access -
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti–Tumor Necrosis Factor Therapy
Caldera, F., Rolak, S., Farraye, F. A., Necela, B. M., Cogen, D., Zona, E. E., Schell, T. L., Ramirez, O. R., Almasry, M., Chun, K., Hayney, M. S. & Knutson, K. L., Apr 1 2024, In: Clinical and translational gastroenterology. 15, 4, e00688.Research output: Contribution to journal › Article › peer-review
Open Access -
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Seligson, N. D., Asmann, Y., Almerey, T., Zayas, Y. C., Edgar, M. A., Attia, S., Knutson, K. L. & Bagaria, S. P., Oct 2024, In: Surgical Oncology. 56, 102125.Research output: Contribution to journal › Article › peer-review